Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL646820 | 1.00 | DPP4 (0.51) | DPP4DPP9 | |
| SCHEMBL645647 | 0.89 | DPP4 (0.49) | DPP4DPP9 | |
| SCHEMBL1378140 | 0.89 | DPP4 (0.49) | DPP4DPP9 | |
| SCHEMBL645803 | 0.85 | DPP4 (0.54) | DPP4DPP9 | |
| SCHEMBL1376692 | 0.85 | DPP4 (0.54) | DPP4DPP9 | |
| SCHEMBL6201221 | 0.83 | DPP4 (0.49) | DPP4DPP9 | |
| SCHEMBL648355 | 0.83 | DPP4 (0.49) | DPP4DPP9 | |
| SCHEMBL6508992 | 0.83 | DPP4 (0.49) | DPP4DPP9 | |
| SCHEMBL3602062 | 0.78 | DPP4 (0.44) | DPP4 | |
| SCHEMBL648644 | 0.78 | DPP4 (0.50) | DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4712387-B2 | — | — | 2011-06-29 | — | — | JP | claimed |
| EP-1560811-A2 | PHARMACEUTICAL COMPOSITIONS AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV (DPP-IV) | Abbott Laboratories (US) | 2005-08-10 | — | — | EP | claimed |
| WO-2004026822-A2 | PHARMACEUTICAL COMPOSITIONS AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV (DPP-IV) | ABBOTT LABORATORIES (US) | 2004-04-01 | — | — | WO | claimed |
| EP-1560811-A2 | PHARMACEUTICAL COMPOSITIONS AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV (DPP-IV) | Abbott Laboratories (US) | 2005-08-10 | — | — | EP | disclosed |
| WO-2004026822-A2 | PHARMACEUTICAL COMPOSITIONS AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV (DPP-IV) | ABBOTT LABORATORIES (US) | 2004-04-01 | — | — | WO | disclosed |